Chief Executive and Operations Officer and Founder: Dr. Syeda Sumaira Andrabi is a general surgeon with over 13 years’ experience. She has worked in a cancer hospital in Pakistan. Dr. Andrabi was the EL in the MD Anderson SW regional short course during Spring 2019, the regional short course at ICAP – Mason in September 2020, and the NSF National I-corps Cohort Spring 2021. She will lead the commercial efforts and serve as PI on the grant.
Founding Scientist: Dr. John Hamre received his PhD from George Mason University in 2021 developing n the technology for cancer drug resistance prediction. He will be leading product development efforts at Pathodynamics.
Outside Technical Director and Founding Scientist: Prof. M. Saleet Jafri is a Professor in the School of Systems Biology and the Director of the Interdisciplinary Program in Neuroscience at George Mason University. He holds affiliate appointments at the Center of Biomedical Engineering and Technology and Department of Physiology at the University of Maryland Baltimore. For this recent innovation, he served as a TL in the MD Anderson SW regional short course during Spring 2019 and more recently at the I-Corps regional short course at ICAP – Mason in September 2020.